Vedroprevir in the management of hepatitis C virus infection.

about

Vedroprevir in the management of hepatitis C virus infection.

Item

http://www.wikidata.org/entity/Q45325957

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Vedroprevir in the management of hepatitis C virus infection.

@en

Vedroprevir in the management of hepatitis C virus infection.

@nl

type

Item

label

Vedroprevir in the management of hepatitis C virus infection.

@en

Vedroprevir in the management of hepatitis C virus infection.

@nl

prefLabel

Vedroprevir in the management of hepatitis C virus infection.

@en

Vedroprevir in the management of hepatitis C virus infection.

@nl

P1476

Vedroprevir in the management of hepatitis C virus infection

@en

P2093

Ameer Abutaleb

http://www.w3.org/2001/XMLSchema#string

Shyamasundaran Kottilil

http://www.w3.org/2001/XMLSchema#string

P2860

The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

Evolving epidemiology of hepatitis C virus

Boceprevir for untreated chronic HCV genotype 1 infection

Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.

Treatment of hepatitis C: a systematic review.

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Abundant drug-resistant NS3 mutants detected by deep sequencing in hepatitis C virus-infected patients undergoing NS3 protease inhibitor monotherapy

Successful Retreatment of Chronic HCV Genotype-1 Infection With Ledipasvir and Sofosbuvir After Initial Short Course Therapy With Direct-Acting Antiviral Regimens.

Prediction of sustained virologic responses to combination therapy of pegylated interferon-α and ribavirin in patients with chronic hepatitis C infection

P304

1399-1402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2017.1395412

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29053394

http://www.w3.org/2001/XMLSchema#string

P932

6463276

http://www.w3.org/2001/XMLSchema#string